Hemgenix is a one-off IV therapy that can cut the number of regular trips to the hospital in half for hemophilia patients – and ultimately reduce health care costs because of fewer bleeding incidents.
Researchers from the University of Pennsylvania analyzed data on 23,442 oncologists in the U.S., evaluating how often doctors affiliated with National Cancer Institute-designated centers were covered by lower-cost insurance plans.
The number of Americans whose cancers were diagnosed at the earliest stage, when its most likely to be cured, increased after Obamacare went into effect and more citizens had access to health insurance, a new study found.
Pfizer Inc. and Allergan Plc agreed to combine in a record $160 billion deal, creating a drugmaking behemoth called Pfizer Plc with products from Viagra to Botox and a low-cost tax base.
New guidelines from the American Cancer Society cut back on the need for mammograms, though they apply only to women with average risk of breast cancer.
CVS Health Corp. posted fourth-quarter earnings that beat analyst estimates as demand for medicine outweighed the drop in revenue from a decision to stop selling tobacco products.
Measles could once again become native in the United States, disease experts worry, as an outbreak in California linked to Disneyland has put a spotlight on a growing failure to vaccinate thats helping the disease to spread.
The laboratory work enables scientists to more easily manipulate white fat cells, the bad kind that stores energy for later use and contributes to obesity and diabetes.
DebugScreen: mobile
{
"author": {
"name": "Michelle Fay Cortez",
"webUrl": "/author/profile/michelle-fay-cortez/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 17,
"social": [],
"articles": [
{
"uri": "/2022/11/28/fda-approves-worlds-most-expensive-drug-to-treat-hemophilia-at-3-5m-a-dose/",
"title": "FDA approves world's most expensive drug at $3.5M a dose",
"byline": "Michelle Fay Cortez",
"kicker": "News",
"prettyDate": "November 28, 2022",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/08/Healthcare_616-372.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Hemgenix is a one-off IV therapy that can cut the number of regular trips to the hospital in half for hemophilia patients – and ultimately reduce health care costs because of fewer bleeding incidents.",
"body": null
},
{
"uri": "/2019/05/29/fda-approves-2-1-million-gene-therapy-drug/",
"title": "FDA approves $2.1 million gene therapy drug",
"byline": "James Paton and Michelle Fay Cortez",
"kicker": "News",
"prettyDate": "May 29, 2019",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/james-paton/",
"name": "James Paton"
},
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Zolgensma, the first drug in the U.S. to cross the $1 million mark, is an important test for the field as a wave of gene therapies advance.",
"body": null
},
{
"uri": "/2017/07/06/low-cost-health-insurance-limits-access-to-top-can/",
"title": "Low-cost health insurance limits access to top cancer doctors",
"byline": " Michelle Fay Cortez, Zachary Tracer ",
"kicker": "",
"prettyDate": "July 06, 2017",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez-zachary-tracer/",
"name": "Michelle Fay Cortez, Zachary Tracer"
}
],
"kickerNode": [],
"summary": "Researchers from the University of Pennsylvania analyzed data on 23,442 oncologists in the U.S., evaluating how often doctors affiliated with National Cancer Institute-designated centers were covered by lower-cost insurance plans.",
"body": null
},
{
"uri": "/2017/05/18/aca-helped-catch-cancer-faster-as-insurance-grew/",
"title": "ACA helped catch cancer faster as insurance grew",
"byline": "Michelle Fay Cortez",
"kicker": "",
"prettyDate": "May 18, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "The number of Americans whose cancers were diagnosed at the earliest stage, when its most likely to be cured, increased after Obamacare went into effect and more citizens had access to health insurance, a new study found.",
"body": null
},
{
"uri": "/2015/11/23/pfizer-allergan-to-combine-in-deal-valued-at-160b/",
"title": "Pfizer, Allergan to combine in deal valued at $160B",
"byline": "Cynthia Koons, Michelle Fay Cortez",
"kicker": "",
"prettyDate": "November 23, 2015",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/cynthia-koons-michelle-fay-cortez/",
"name": "Cynthia Koons, Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "Pfizer Inc. and Allergan Plc agreed to combine in a record $160 billion deal, creating a drugmaking behemoth called Pfizer Plc with products from Viagra to Botox and a low-cost tax base.",
"body": null
},
{
"uri": "/2015/10/20/acs-changes-mammogram-guidelines/",
"title": "ACS changes mammogram guidelines",
"byline": "Michelle Fay Cortez",
"kicker": "",
"prettyDate": "October 20, 2015",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "New guidelines from the American Cancer Society cut back on the need for mammograms, though they apply only to women with average risk of breast cancer.",
"body": null
},
{
"uri": "/2015/02/19/ppaca-not-much-of-a-burden/",
"title": "PPACA not much of a burden",
"byline": "Michelle Fay Cortez, Alex Wayne",
"kicker": "",
"prettyDate": "February 19, 2015",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez-alex-wayne/",
"name": "Michelle Fay Cortez, Alex Wayne"
}
],
"kickerNode": [],
"summary": "The biggest entitlement legislation in a generation is causing barely a ripple in corporate America.",
"body": null
},
{
"uri": "/2015/02/10/cvs-kicks-the-habit-beats-estimates/",
"title": "CVS kicks the habit, beats estimates",
"byline": "Michelle Fay Cortez",
"kicker": "",
"prettyDate": "February 10, 2015",
"timeToRead": "2 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "CVS Health Corp. posted fourth-quarter earnings that beat analyst estimates as demand for medicine outweighed the drop in revenue from a decision to stop selling tobacco products.",
"body": null
},
{
"uri": "/2015/01/26/measles-threatens-comeback/",
"title": "Measles threatens comeback",
"byline": "Anna Edney, Michelle Fay Cortez",
"kicker": "",
"prettyDate": "January 26, 2015",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/anna-edney-michelle-fay-cortez/",
"name": "Anna Edney, Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "Measles could once again become native in the United States, disease experts worry, as an outbreak in California linked to Disneyland has put a spotlight on a growing failure to vaccinate thats helping the disease to spread.",
"body": null
},
{
"uri": "/2014/12/08/fat-burning-pill-closer-to-reality/",
"title": "Fat-burning pill closer to reality",
"byline": "Michelle Fay Cortez",
"kicker": "",
"prettyDate": "December 08, 2014",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/michelle-fay-cortez/",
"name": "Michelle Fay Cortez"
}
],
"kickerNode": [],
"summary": "The laboratory work enables scientists to more easily manipulate white fat cells, the bad kind that stores energy for later use and contributes to obesity and diabetes.",
"body": null
}
]
}
}
